Sign In
Buy SYK
$335.96
-5.24 (-1.54%)
At Close: Aug 04, 2026
Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics?
10:01am, Friday, 24'th Oct 2025
Stryker's Q3 results are expected to highlight MedSurg strength and solid robotics-led growth in Orthopaedics, partly offset by tariff headwinds.
Beware The Death Cross: 3 Stocks Triggering This Spooky Signal
07:11am, Wednesday, 22'nd Oct 2025
There are two types of Halloween people: those who like jump scares and those who don't. But even if you're a fan of haunted hayrides and movies like The Conjuring, you probably don't want to ever get
Buy 3 Wide Moat Stocks to Enhance Your Portfolio Returns in Q4
10:21am, Tuesday, 21'st Oct 2025
MCO, SYK and CBRE stand out as wide moat stocks with strong growth forecasts and strategic expansions to boost portfolio resilience.
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
11:51am, Friday, 17'th Oct 2025
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. SYK, NVDA, RMD and RL hold promise.
Stryker to Feature Expanding Trauma Portfolio at the Orthopaedic Trauma Association Annual Meeting 2025
08:10am, Tuesday, 14'th Oct 2025
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker will showcase new additions to its trauma offerings at the Orthopaedic Trauma Association Annual Meeting, October 15–18, in Phoenix, Ariz.
SNN or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 08'th Oct 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the bette
Stryker to announce financial results for its third quarter of fiscal year 2025
08:00am, Wednesday, 01'st Oct 2025
Portage, Michigan, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its third quarter of fiscal year 2025 on Thursday, October 30, 2025. A pre
Robotics and MedSurg Drive Stryker Growth Amid Margin Pressures
09:51am, Wednesday, 24'th Sep 2025
SYK posts 11% sales growth and EPS beat for Q2, driven by Mako robotics and MedSurg strength, but faces cost and margin headwinds.
Stryker Expands R&D Facility in India to Boost Medtech Innovation
01:36pm, Monday, 22'nd Sep 2025
SYK expands its Bangalore R&D hub to accelerate robotics, AI and digital health innovation while deepening ties with India's talent pool.
SNN vs. SYK: Which Stock Is the Better Value Option?
12:40pm, Monday, 22'nd Sep 2025
Investors interested in stocks from the Medical - Products sector have probably already heard of Smith & Nephew (SNN) and Stryker (SYK). But which of these two companies is the best option for those l
SYK Partners With Siemens Healthineers to Boost Stroke, Aneurysm Care
11:06am, Thursday, 18'th Sep 2025
Stryker teams with Siemens Healthineers to develop a robotic ecosystem aimed at advancing stroke and aneurysm care.
Stryker Launches Incompass Total Ankle System at AOFAS 2025
07:20am, Tuesday, 09'th Sep 2025
PORTAGE, Mich.--(BUSINESS WIRE)--Stryker will launch its Incompass™ Total Ankle System at the 2025 AOFAS Annual Meeting in Savannah, Georgia, September 10–13, 2025 (booth # 401).
Stryker Corporation (SYK) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
05:33pm, Thursday, 04'th Sep 2025
Stryker Corporation (NYSE:SYK ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 2:15 PM EDT Company Participants Jason Beach - Vice President of Finance & Investor Relations J. Pi
SNN or SYK: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 02'nd Sep 2025
Investors with an interest in Medical - Products stocks have likely encountered both Smith & Nephew (SNN) and Stryker (SYK). But which of these two stocks presents investors with the better value oppo
Investing in the Age of Longevity: Silver Economy Stocks in Focus
01:16pm, Monday, 01'st Sep 2025
AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.
